Literature DB >> 33609264

Research progress of natural compounds in anti-liver fibrosis by affecting autophagy of hepatic stellate cells.

Yongxiang Shu1, Xuyou Liu1, Haifeng Huang1, Qi Wen1, Jianchang Shu2.   

Abstract

Chronic liver diseases caused by various pathogenesis are marked by inflammatory infiltration and wound healing reaction, while their normal regeneration ability is impaired. The unbalance between the generation and the degradation of extracellular matrix (ECM) leads to collagen accumulation and develops into liver fibrosis. Inflammation, oxidative stress, and autophagy interact closely in the pathogenesis of hepatic fibrosis. Reactive Oxygen Species (ROS) can not only stimulate Kupffer cells to release massive inflammatory factors, but induce autophagy. However, the latter may suppress inflammatory reaction by inhibiting proinflammatory complex formation directly, and removing damaged organelles or pathogenic microorganism indirectly. At present, effective anti-fibrosis drugs are still lacking. Previous studies have found various natural compounds enabled liver protection through anti-inflammatory, antioxidant, and other mechanisms. In recent years, autophagy, a vital life activity, has been found to be involved in the mechanism of liver fibrosis. As a new target, developing anti-liver fibrosis drugs that regulate the activity of autophagy is very promising. In this review, we summarize the latest studies about natural compounds in the treatment of liver fibrosis by regulating autophagy.

Entities:  

Keywords:  Apoptosis; Hepatic stellate cell; Liver fibrosis; Natural compound autophagy; Senescence

Mesh:

Substances:

Year:  2021        PMID: 33609264      PMCID: PMC7925445          DOI: 10.1007/s11033-021-06171-w

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  36 in total

Review 1.  Hepatic Fibrosis: Emerging Therapies.

Authors:  Scott L Friedman
Journal:  Dig Dis       Date:  2015-07-06       Impact factor: 2.404

Review 2.  Cellular networks in hepatic fibrosis.

Authors:  S L Friedman
Journal:  Digestion       Date:  1998 Jul-Aug       Impact factor: 3.216

Review 3.  Hepatic fibrosis: Concept to treatment.

Authors:  Christian Trautwein; Scott L Friedman; Detlef Schuppan; Massimo Pinzani
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

Review 4.  Functions of autophagy in hepatic and pancreatic physiology and disease.

Authors:  Mark J Czaja
Journal:  Gastroenterology       Date:  2011-04-23       Impact factor: 22.682

Review 5.  Reversal of hepatic fibrosis -- fact or fantasy?

Authors:  Scott L Friedman; Meena B Bansal
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 6.  Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

Authors:  Geoffrey C Farrell; Claire Z Larter
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

7.  LC3 and Autophagy.

Authors:  Isei Tanida; Takashi Ueno; Eiki Kominami
Journal:  Methods Mol Biol       Date:  2008

Review 8.  Hepatic stellate cells as key target in liver fibrosis.

Authors:  Takaaki Higashi; Scott L Friedman; Yujin Hoshida
Journal:  Adv Drug Deliv Rev       Date:  2017-05-12       Impact factor: 17.873

9.  Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell.

Authors:  Zili Zhang; Shifeng Zhao; Zhen Yao; Ling Wang; Jiangjuan Shao; Anping Chen; Feng Zhang; Shizhong Zheng
Journal:  Redox Biol       Date:  2016-12-21       Impact factor: 11.799

10.  Autophagy defects and related genetic variations in renal cell carcinoma with eosinophilic cytoplasmic inclusions.

Authors:  Zhou Yu; Jing Ma; Xia Li; Yixiong Liu; Mingyang Li; Lu Wang; Ming Zhao; Huiying He; Yifen Zhang; Qiu Rao; Danhui Zhao; Yingmei Wang; Linni Fan; Peifeng Li; Yang Liu; Fang Liu; Feng Zhang; Jing Ye; Qingguo Yan; Shuangping Guo; Zhe Wang
Journal:  Sci Rep       Date:  2018-07-02       Impact factor: 4.379

View more
  3 in total

1.  miR221 regulates TGF-β1-induced HSC activation through inhibiting autophagy by directly targeting LAMP2.

Authors:  Ran Cheng; Hao Xu; Yang Hong
Journal:  Mol Med Rep       Date:  2021-09-09       Impact factor: 2.952

2.  Modulation of hepatic stellate cells by Mutaflor® probiotic in non-alcoholic fatty liver disease management.

Authors:  Noha M Hany; Sanaa Eissa; Manal Basyouni; Amany H Hasanin; Yasmin M Aboul-Ela; Nagwa M Abo Elmagd; Iman F Montasser; Mahmoud A Ali; Paul J Skipp; Marwa Matboli
Journal:  J Transl Med       Date:  2022-07-30       Impact factor: 8.440

Review 3.  Oroxylin A: A Promising Flavonoid for Prevention and Treatment of Chronic Diseases.

Authors:  Anjana Sajeev; Mangala Hegde; Sosmitha Girisa; Thulasidharan Nair Devanarayanan; Mohammed S Alqahtani; Mohamed Abbas; Samir Kumar Sil; Gautam Sethi; Jen-Tsung Chen; Ajaikumar B Kunnumakkara
Journal:  Biomolecules       Date:  2022-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.